Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

30 Oct 2020 | 04:01 PM

476.00
6.25 (1.33%)

  • Outperforms Index

    50.82%

    Return (1Y)

    Beaten S&P BSE Healthcare by 3.85%

  • More Volatile

    3.99%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.33%

  • Not so consistent

    6/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

573

572.70

168

168.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glenmark Pharmaceuticals Ltd has increased by 10.21% since past 3 Months

  • MF shareholding in Glenmark Pharmaceuticals Ltd has increased by 51.36% since past 3 Months

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.79% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.37% since past 1 Year

Loading...